A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

NCT07412470 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant Rejection

Interventions

DRUG: Frexalimab
DRUG: Frexalimab
DRUG: Tacrolimus
DRUG: rabbit anti-thymocyte globulin
DRUG: mycophenolate mofetil
DRUG: mycophenolate sodium
DRUG: methylprednisolone
DRUG: prednisone

Sponsor

Sanofi